Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

INSM

Insmed (INSM)

Insmed Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:INSM

<< Précédent 1 2 3 4 5 6 7 8 9 10 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
16/02/2021	14h00	PR Newswire (US)	Insmed to Host Conference Call to Discuss Topline Data from Treprostinil Palmitil Inhalation Powder Phase 1 Study	NASDAQ:INSM	Insmed Inc
12/02/2021	14h00	PR Newswire (US)	Insmed to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call on Thursday, February 25, 2021	NASDAQ:INSM	Insmed Inc
11/02/2021	22h34	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:INSM	Insmed Inc
10/02/2021	22h10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INSM	Insmed Inc
05/02/2021	14h00	PR Newswire (US)	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:INSM	Insmed Inc
11/01/2021	12h32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:INSM	Insmed Inc
05/01/2021	14h00	PR Newswire (US)	Insmed to Present at the 39th Annual J.P. Morgan Healthcare Conference	NASDAQ:INSM	Insmed Inc
04/01/2021	14h00	PR Newswire (US)	Insmed Initiates Frontline Clinical Trial Program for ARIKAYCE® (amikacin liposome inhalation suspension) in Patients with M...	NASDAQ:INSM	Insmed Inc
02/12/2020	14h00	PR Newswire (US)	Insmed Announces Initiation of Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis	NASDAQ:INSM	Insmed Inc
24/11/2020	14h00	PR Newswire (US)	Insmed to Present at the Evercore ISI 3rd Annual HealthCONx Conference	NASDAQ:INSM	Insmed Inc
13/11/2020	14h00	PR Newswire (US)	Insmed Receives Priority Medicines (PRIME) Designation from European Medicines Agency (EMA) for Brensocatib in Patients with ...	NASDAQ:INSM	Insmed Inc
02/11/2020	14h00	PR Newswire (US)	Insmed to Present at Two November Conferences	NASDAQ:INSM	Insmed Inc
29/10/2020	12h30	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:INSM	Insmed Inc
29/10/2020	12h30	PR Newswire (US)	Insmed Reports Third Quarter 2020 Financial Results and Provides Business Update	NASDAQ:INSM	Insmed Inc
28/10/2020	12h37	PR Newswire (US)	European Commission Grants Marketing Authorization for ARIKAYCE® Liposomal 590 mg Nebuliser Dispersion for the Treatment of ...	NASDAQ:INSM	Insmed Inc
20/10/2020	14h00	PR Newswire (US)	Insmed to Host Third Quarter 2020 Financial Results Conference Call on Thursday, October 29, 2020	NASDAQ:INSM	Insmed Inc
30/09/2020	14h00	PR Newswire (US)	Insmed Highlights Progress Across Portfolio and Outlines Growth Strategy at R&D Day	NASDAQ:INSM	Insmed Inc
16/09/2020	14h00	PR Newswire (US)	Insmed to Host R&D Day on September 30, 2020	NASDAQ:INSM	Insmed Inc
09/09/2020	22h05	PR Newswire (US)	Insmed to Present at Three September Conferences	NASDAQ:INSM	Insmed Inc
07/09/2020	17h24	PR Newswire (US)	New England Journal of Medicine Publishes Positive Results from Phase 2 WILLOW Study of Brensocatib in Patients with Non-Cyst...	NASDAQ:INSM	Insmed Inc
06/08/2020	13h30	PR Newswire (US)	Insmed Reports Second Quarter 2020 Financial Results and Provides Business Update	NASDAQ:INSM	Insmed Inc
27/07/2020	14h00	PR Newswire (US)	Insmed to Host Second Quarter 2020 Financial Results Conference Call on Thursday, August 6, 2020	NASDAQ:INSM	Insmed Inc
24/07/2020	13h39	PR Newswire (US)	Insmed Receives Positive CHMP Opinion for ARIKAYCE Liposomal 590 mg Nebuliser Dispersion for the Treatment of NTM Lung Infect...	NASDAQ:INSM	Insmed Inc
07/07/2020	14h00	PR Newswire (US)	New NTM Treatment Guidelines Recommend Insmed's ARIKAYCE® (amikacin liposome inhalation suspension) for Treatment of Patient...	NASDAQ:INSM	Insmed Inc
24/06/2020	22h01	PR Newswire (US)	Positive Results from Phase 2 WILLOW Study of Brensocatib in Patients with Non-Cystic Fibrosis Bronchiectasis Presented at AT...	NASDAQ:INSM	Insmed Inc
08/06/2020	14h00	PR Newswire (US)	Insmed Receives FDA Breakthrough Therapy Designation for Brensocatib in Patients with Non-Cystic Fibrosis Bronchiectasis (NCF...	NASDAQ:INSM	Insmed Inc
26/05/2020	14h00	PR Newswire (US)	Insmed to Present at Two June Conferences	NASDAQ:INSM	Insmed Inc
21/05/2020	22h10	Edgar (US Regulatory)	Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)	NASDAQ:INSM	Insmed Inc
21/05/2020	22h08	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:INSM	Insmed Inc
20/05/2020	15h29	PR Newswire (US)	Insmed to Showcase New Brensocatib Data at American Thoracic Society Virtual Clinical Trials Session	NASDAQ:INSM	Insmed Inc

Showing the most relevant articles for your search:NASDAQ:INSM

<< Précédent 1 2 3 4 5 6 7 8 9 10 Suivant >>

Troymet Exploration Corp.

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales